title: FDG-PET/CT for cancer management.
abstract: FDG-PET/CT is increasingly being used for staging, restaging, and treatment monitoring for cancer patients. The introduction of a PET/CT system enables both morphological and metabolic imaging to be performed in a single session. Knowledge of the normal physiologic distribution of FDG and an understanding of the clinical indications and limitations of PET/CT enable accurate diagnosis and thus a better level of care for patients.
authors: Department of Radiology, Institute of Health Biosciences, The University of Tokushima, Graduate School, Tokushima, Japan.
authors: Hideki
authors: H
authors: Otsuka
authors: Naomi
authors: N
authors: Morita
authors: Kyo
authors: K
authors: Yamashita
authors: Hiromu
authors: H
authors: Nishitani
mesh_terms: D000368:Aged; D005260:Female; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000628:therapy; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed
chemical_list: D005462:Fluorine Radioisotopes; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18